Evidence map›Paper›PMID 36774149›Full record

ArticleLancet (London, England)2023

Conflicting COVID-19 excess mortality estimates.

Matshidiso Moeti, Lindiwe Makubalo, Abdou Salam Gueye, Thierno Balde, Humphrey Karamagi, Gordon Awandare, S M Thumbi, Feifei Zhang, Francisca Mutapi, Mark Woolhouse

Abstract readLetterComment
In one paragraph

Article in Lancet (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Matshidiso MoetiWHO Regional Office for Africa, Brazzaville, Democratic Republic of the Congo.
Lindiwe MakubaloWHO Regional Office for Africa, Brazzaville, Democratic Republic of the Congo.
Abdou Salam GueyeWHO Regional Office for Africa, Brazzaville, Democratic Republic of the Congo.
Thierno BaldeWHO Regional Office for Africa, Brazzaville, Democratic Republic of the Congo.
Humphrey KaramagiWHO Regional Office for Africa, Brazzaville, Democratic Republic of the Congo.
Gordon AwandareWest African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana.
S M ThumbiCenter for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya; Paul G. Allen School for Global Health, Washington State University, Pullman, WA, USA; Tackling Infections to Benefit Africa, University of Edinburgh, Edinburgh EH9 3FL, UK.
Feifei ZhangNational Institute of Health Data Science, Peking University, Beijing, China; Tackling Infections to Benefit Africa, University of Edinburgh, Edinburgh EH9 3FL, UK.
Francisca MutapiTackling Infections to Benefit Africa, University of Edinburgh, Edinburgh EH9 3FL, UK.
Mark WoolhouseTackling Infections to Benefit Africa, University of Edinburgh, Edinburgh EH9 3FL, UK. Electronic address: mark.woolhouse@ed.ac.uk.

Funding

Infectious Diseases and Microbial Immunology Training ProgramT32AI007025 · NIAID · WASHINGTON STATE UNIVERSITY · PI Thomas H KAWULA, M KARIUKI NJENGA · 1985 to 2026
$7.4M
Zoonotic and Emerging Infectious Diseases Training ProgramD43TW011519 · FIC · WASHINGTON STATE UNIVERSITY · PI Walter Godfrey Jaoko, Thumbi Mwangi · 2020 to 2026
$1.2M
FIC NIH HHS D43 TW011519NIAID NIH HHS T32 AI007025World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansMortality

Identifiers

PMID36774149
PMCPMC9910847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.